Kantrex Related Published Studies
Well-designed clinical trials related to Kantrex (Kanamycin)
Effects of prolonged kanamycin administration on cochlear anatomy and auditory brainstem response thresholds in chickens. [2008.05]
Topical kanamycin: an effective therapeutic option in aerobic vaginitis. [2006.08]
Well-designed clinical trials possibly related to Kantrex (Kanamycin)
Randomized clinical trial of perioperative selective decontamination of the digestive tract versus placebo in elective gastrointestinal surgery. [2011.10]
Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. [2011.09]
Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity. [2011.08]
Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. [2011.07.01]
Effects of intracameral triamcinolone and gentamicin injections following cataract surgery. [2011.07]
Population pharmacokinetics of amikacin in a Korean clinical population. [2011.06]
Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia. [2011.05]
Higher tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis. [2011.04]
The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis. [2011.02]
Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis. [2011.01]
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial. [2011.01]
Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis. [2011.01]
Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects. [2011.01]
Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. [2011]
Randomized clinical trial of perioperative selective decontamination of the
digestive tract versus placebo in elective gastrointestinal surgery. [2011]
Efficacy and safety of netilmycin/dexamethasone preservative-free and tobramycin/dexamethasone-preserved fixed combination in patients after cataract surgery. [2010.12]
Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations. [2010.12]
[On the topical tolerance of aminoglycoside antibiotics--a prospective comparative cytomorphological study]. [2010.10]
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital. [2010.08]
Impact of infusion method on amikacin serum levels in humans. [2010.08]
A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. [2010.08]
The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study. [2010.08]
Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. [2010.07]
The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease. [2010.05]
[Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis] [2010.04]
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial. [2010.04]
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. [2010.04]
Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients. [2010.03]
Is perioperative intravesically applied antibiotic solution effective in the prophylaxis of urinary tract infections after renal transplantation? [2010]
Effect of topical application of 1% diclofenac sodium liposomal cream on inflammation in healthy horses undergoing intravenous regional limb perfusion with amikacin sulfate. [2009.11]
Evaluation of indwelling intravenous catheters for the regional perfusion of the limbs of horses. [2009.10.24]
Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis. [2009.10]
[Study of different methods in reducing conjunctival bacteria before cataract surgery] [2009.09.22]
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia. [2009.09]
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis. [2009.09]
[Treatment of urinary tract infections in febrile infants: Experience of outpatient intravenous antibiotic treatment.] [2009.08]
[Comparison between two antibiotic schemes in relation to surgical site infection in children: a randomized clinical trial] [2009.07]
Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. [2009.05]
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison. [2009.04]
Pharmacokinetics of tobramycin in ducks and sex-related differences. [2009.03]
Evaluation of polysulfated glycosaminoglycan or sodium hyaluronan administered intra-articularly for treatment of horses with experimentally induced osteoarthritis. [2009.02]
Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infections. [2009.01]
Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: results of a prospective randomized trial. [2009]
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients. [2008.12]
Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis. [2008.11]
Fibrin glue versus sutures for conjunctival autografting in pterygium surgery: a prospective comparative study. [2008.09]
Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressor. [2008.09]
Tolerability of loteprednol/tobramycin versus dexamethasone/tobramycin in healthy volunteers: results of a 4-week, randomized, double-masked, parallel-group study. [2008.08]
Vestibular system in infants after systemic therapy with amikacin. [2008.08]
Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia. [2008.08]
A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients. [2008.07]
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. [2008.06]
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India. [2008.06]
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients. [2008.05]
An evaluation of amikacin nephrotoxicity in the hematology/oncology population. [2008.03]
Comparison of two indirect techniques for local delivery of a high dose of an antimicrobial in the distal portion of forelimbs of horses. [2008.03]
Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis. [2008.03]
Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers. [2008.01]
Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis. [2008.01]
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study. [2007.11]
[Dynamic changes of blister fluid amikacin concentration after its early-stage administration in severely burned patients] [2007.10]
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. [2007.09]
Control of inflammation and prophylaxis of endophthalmitis after cataract surgery: A multicenter study. [2007.09]
Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics. [2007.09]
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis. [2007.09]
Phase 3 Safety Comparisons for 1.0% Azithromycin in Polymeric Mucoadhesive Eye Drops versus 0.3% Tobramycin Eye Drops for Bacterial Conjunctivitis. [2007.08]
No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations. [2007.07]
Effects of preoperatively selected gut decontamination on cardiopulmonary bypassjinduced endotoxemia. [2007.06]
3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. [2007.04]
Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety. [2007.04]
Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. [2007.04]
Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis. [2007.04]
Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. [2007.03]
Efficacy and renal toxicity of one daily dose of amikacin versus conventional dosage regime. [2007.02]
Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. [2007.02]
Effect of intrathecal amikacin administration and repeated centesis on digital flexor tendon sheath synovial fluid in horses. [2007.01]
Dexamethasone-netilmicin: a new ophthalmic steroid-antibiotic combination. Efficacy and safety after cataract surgery. [2007.01]
Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis. [2007.01]
Dexamethasone-netilmicin: a new ophthalmic steroid-antibiotic combination. Efficacy and safety after cataract surgery. [2007.01]
A Formulation of Aerosolized Tobramycin (Bramitob((R))) in the Treatment of Patients with Cystic Fibrosis and Pseudomonas aeruginosa Infection : A Double-Blind, Placebo-Controlled, Multicenter Study. [2007]
Efficacy, Safety, and Local Pharmacokinetics of Highly Concentrated Nebulized Tobramycin in Patients with Cystic Fibrosis Colonized with Pseudomonas aeruginosa. [2007]
Clinical Pharmacology Study of Bramitob((R)), a Tobramycin Solution for Nebulization, in Comparison with Tobi((R)). [2007]
High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients. [2006.12]
Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis. [2006.12]
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. [2006.11]
Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? [2006.10]
[Comparative study between tobramicin and tobramicin plus ciprofloxacin in transrectal prostate biopsy prophylaxis] [2006.10]
Impact of ibuprofen administration on renal drug clearance in the first weeks of life. [2006.10]
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia. [2006.09]
Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients. [2006.07]
Effects of supplementation of beta-glucans on growth performance, nutrient digestibility, and immunity in weanling pigs. [2006.06]
Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis. [2006.02]
Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial. [2006.02]
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. [2006.02]
Inhaled tobramycin in children with acute bacterial rhinopharyngitis. [2006.01]
Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. [2005.11.21]
Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II. [2005.11]
Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis. [2005.10.15]
The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. [2005.10]
|
